It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The gut microbiome is a potential non-genetic contributing factor for Amyotrophic Lateral Sclerosis. Differences in gut microbial communities have been detected between ALS subjects and healthy controls, including an increase in Escherichia coli in ALS subjects. E. coli and other gram-negative bacteria produce curli proteins, which are functional bacterial amyloids. We examined whether long-term curli overexposure in the gut can exacerbate the development and progression of ALS. We utilized the slow-developing hSOD1-G93A mouse model of ALS with their C57BL/6J WT littermate controls, including males and females, with a total of 91 animals. These mice were on a normal chow diet and fed curli-producing or curli-nonproducing (mutant) E. coli in applesauce (vehicle) 3 times/week, from 1 through 7 months of age. Male hSOD1 mice demonstrated gradual slowing in running speed month 4 onwards, while females exhibited no signs of locomotive impairment even at 7 months of age. Around the same time, male hSOD1 mice showed a gradual increase in frequency of peripheral CD19+ B cells. Among the male hSOD1 group, chronic gut exposure to curli-producing E. coli led to significant shifts in α- and β-diversities. Curli-exposed males showed suppression of immune responses in circulation, but an increase in markers of inflammation, autophagy and protein turnover in skeletal muscle. Some of these markers were also changed in mutant E. coli-exposed mice, including astrogliosis in the brainstem and demyelination in the lumbar spinal cord. Overall, chronic overexposure to a commensal bacteria like E. coli led to distant organ pathology in our model, without the presence of a leaky gut at 6 months. Mechanisms underlying gut-distant organ communication are of tremendous interest to all disciplines.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University of Louisville, Department of Neurology, Louisville, USA (GRID:grid.266623.5) (ISNI:0000 0001 2113 1622)
2 University of South Florida, Department of Neuroscience, Tampa, USA (GRID:grid.170693.a) (ISNI:0000 0001 2353 285X)
3 University of Louisville, KY IDeA Networks of Biomedical Research Excellence Bioinformatics Core, Louisville, USA (GRID:grid.266623.5) (ISNI:0000 0001 2113 1622)
4 University of Louisville, Kentucky Spinal Cord Injury Research Center, Louisville, USA (GRID:grid.266623.5) (ISNI:0000 0001 2113 1622)
5 University of Louisville, Department of Pharmacology and Toxicology, Louisville, USA (GRID:grid.266623.5) (ISNI:0000 0001 2113 1622)
6 NIH, National Institute on Aging, Translational Gerontology, Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165)
7 University of Louisville, School of Medicine, Louisville, USA (GRID:grid.266623.5) (ISNI:0000 0001 2113 1622)